Acute disseminated encephalomyelitis future or investigational therapies: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acute disseminated encephalomyelitis}} | {{Acute disseminated encephalomyelitis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Sujaya}} | ||
==Overview== | |||
{{ | The use of emerging [[therapies]] has not been reported in patients with [[acute]] [[demyelinating]] [[diseases]] like [[ADEM]]. | ||
==Future or [[Investigational]] [[Therapies]]== | |||
The use of emerging [[therapies]] has not been reported in patients with [[acute]] [[demyelinating]] [[diseases]] like [[ADEM]]<ref name="pmid22476745">{{cite journal| author=Pohl D, Tenembaum S| title=Treatment of acute disseminated encephalomyelitis. | journal=Curr Treat Options Neurol | year= 2012 | volume= 14 | issue= 3 | pages= 264-75 | pmid=22476745 | doi=10.1007/s11940-012-0170-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22476745 }} </ref>. | |||
==References== | ==References== | ||
| Line 13: | Line 13: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} | ||
Latest revision as of 09:49, 22 November 2022
|
Acute disseminated encephalomyelitis Microchapters |
|
Differentiating Acute disseminated encephalomyelitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute disseminated encephalomyelitis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Acute disseminated encephalomyelitis future or investigational therapies |
|
FDA on Acute disseminated encephalomyelitis future or investigational therapies |
|
CDC on Acute disseminated encephalomyelitis future or investigational therapies |
|
Acute disseminated encephalomyelitis future or investigational therapies in the news |
|
Blogs on Acute disseminated encephalomyelitis future or investigational therapies |
|
Directions to Hospitals Treating Acute disseminated encephalomyelitis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]
Overview
The use of emerging therapies has not been reported in patients with acute demyelinating diseases like ADEM.
Future or Investigational Therapies
The use of emerging therapies has not been reported in patients with acute demyelinating diseases like ADEM[1].
References
- ↑ Pohl D, Tenembaum S (2012). "Treatment of acute disseminated encephalomyelitis". Curr Treat Options Neurol. 14 (3): 264–75. doi:10.1007/s11940-012-0170-0. PMID 22476745.